FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2003183855> ?p ?o ?g. }

• W2003183855 endingPage "420" @default.
• W2003183855 startingPage "406" @default.
• W2003183855 abstract "FPyME (1-[3-(2-fluoropyridin-3-yloxy)propyl]pyrrole-2,5-dione) was designed as a [18F]fluoropyridine-based maleimide reagent for the prosthetic labeling of peptides and proteins via selective conjugation with a thiol (sulfhydryl) function. Its pyridinyl moiety carries the radioactive halogen (fluorine-18) which can be efficiently incorporated via a nucleophilic heteroaromatic substitution, and its maleimido function ensures the efficient alkylation of a free thiol function as borne by cysteine residues. [18F]FPyME (HPLC-purified) was prepared in 17−20% non-decay-corrected yield, based on starting [18F]fluoride, in 110 min using a three-step radiochemical pathway. The developed procedure involves (1) a high-yield nucleophilic heteroaromatic ortho-radiofluorination on [3-(3-tert-butoxycarbonylaminopropoxy)pyridin-2-yl]trimethylammonium trifluoromethanesulfonate as the fluorine-18 incorporation step, followed by (2) rapid and quantitative TFA-induced removal of the N-Boc-protective group and (3) optimized maleimide formation using N-methoxycarbonylmaleimide. Typically, 4.8−6.7 GBq (130−180 mCi) of radiochemically pure [18F]FPyME ([18F]-1) could be obtained after semipreparative HPLC in 110 min starting from a cyclotron production batch of 33.3 GBq (900 mCi) of [18F]fluoride (overall radiochemical yields, based on starting [18F]fluoride: 28−37% decay-corrected). [18F]FPyME ([18F]-1) was first conjugated with a small model hexapeptide ((N-Ac)KAAAAC), confirming the excellent chemoselectivity of the coupling reaction (CH2SH versus CH2NH2) and then conjugated with two 8-kDa proteins of interest, currently being developed as tumor imaging agents (c-AFIM-0 and c-STxB). Conjugation was achieved in high yields (60−70%, isolated and non-decay-corrected) and used optimized, short-time reaction conditions (a 1/9 (v/v) mixture of DMSO and 0.05 M aq Tris NaCl buffer (pH 7.4) or 0.1 M aq PBS (pH 8), at room temperature for 10 min) and purification conditions (a gel filtration using a Sephadex NAP-10 cartridge or a SuperDex Peptide HR 10/30 column), both compatible with the chemical stability of the proteins and the relatively short half-life of the radioisotope concerned. The whole radiosynthetic procedure, including the preparation of the fluorine-18-labeled reagent, the conjugation with the protein and the final purification took 130−140 min. [18F]FPyME ([18F]-1) represents a new, valuable, thiol-selective, fluorine-18-labeled reagent for the prosthetic labeling with fluorine-18 of peptides and proteins. Because of its excellent chemoselectivity, [18F]FPyME offers an interesting alternative to the use of the nonselective carboxylate and amine-reactive [18F]reagents and can therefore advantageously be used for the design and development of new peptide- and protein-based radiopharmaceuticals for PET." @default.
• W2003183855 created "2016-06-24" @default.
• W2003183855 creator A5001522381 @default.
• W2003183855 creator A5020935626 @default.
• W2003183855 creator A5027857058 @default.
• W2003183855 creator A5032382237 @default.
• W2003183855 creator A5038794107 @default.
• W2003183855 creator A5050083590 @default.
• W2003183855 creator A5053303835 @default.
• W2003183855 creator A5078236467 @default.
• W2003183855 creator A5080931242 @default.
• W2003183855 creator A5088407181 @default.
• W2003183855 date "2005-02-25" @default.
• W2003183855 modified "2023-10-15" @default.
• W2003183855 title "1-[3-(2-[¹⁸F]Fluoropyridin-3-yloxy)propyl]pyrrole-2,5-dione: Design, Synthesis, and Radiosynthesis of a New [¹⁸F]Fluoropyridine-Based Maleimide Reagent for the Labeling of Peptides and Proteins" @default.
• W2003183855 cites W1963615120 @default.
• W2003183855 cites W1991074448 @default.
• W2003183855 cites W2012735547 @default.
• W2003183855 cites W2024318426 @default.
• W2003183855 cites W2024629268 @default.
• W2003183855 cites W2027876673 @default.
• W2003183855 cites W2035625594 @default.
• W2003183855 cites W2040051236 @default.
• W2003183855 cites W2050852845 @default.
• W2003183855 cites W2065150505 @default.
• W2003183855 cites W2068160158 @default.
• W2003183855 cites W2076888828 @default.
• W2003183855 cites W2115470717 @default.
• W2003183855 cites W2165097339 @default.
• W2003183855 cites W2165114902 @default.
• W2003183855 cites W2165510983 @default.
• W2003183855 cites W2316474102 @default.
• W2003183855 cites W2478523459 @default.
• W2003183855 cites W578937435 @default.
• W2003183855 cites W653015837 @default.
• W2003183855 doi "https://doi.org/10.1021/bc0497463" @default.
• W2003183855 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15769096" @default.
• W2003183855 hasPublicationYear "2005" @default.
• W2003183855 type Work @default.
• W2003183855 sameAs 2003183855 @default.
• W2003183855 citedByCount "106" @default.
• W2003183855 countsByYear W20031838552012 @default.
• W2003183855 countsByYear W20031838552013 @default.
• W2003183855 countsByYear W20031838552014 @default.
• W2003183855 countsByYear W20031838552015 @default.
• W2003183855 countsByYear W20031838552016 @default.
• W2003183855 countsByYear W20031838552017 @default.
• W2003183855 countsByYear W20031838552018 @default.
• W2003183855 countsByYear W20031838552019 @default.
• W2003183855 countsByYear W20031838552020 @default.
• W2003183855 countsByYear W20031838552021 @default.
• W2003183855 countsByYear W20031838552022 @default.
• W2003183855 crossrefType "journal-article" @default.
• W2003183855 hasAuthorship W2003183855A5001522381 @default.
• W2003183855 hasAuthorship W2003183855A5020935626 @default.
• W2003183855 hasAuthorship W2003183855A5027857058 @default.
• W2003183855 hasAuthorship W2003183855A5032382237 @default.
• W2003183855 hasAuthorship W2003183855A5038794107 @default.
• W2003183855 hasAuthorship W2003183855A5050083590 @default.
• W2003183855 hasAuthorship W2003183855A5053303835 @default.
• W2003183855 hasAuthorship W2003183855A5078236467 @default.
• W2003183855 hasAuthorship W2003183855A5080931242 @default.
• W2003183855 hasAuthorship W2003183855A5088407181 @default.
• W2003183855 hasConcept C134121241 @default.
• W2003183855 hasConcept C135731615 @default.
• W2003183855 hasConcept C150903083 @default.
• W2003183855 hasConcept C155647269 @default.
• W2003183855 hasConcept C161790260 @default.
• W2003183855 hasConcept C177322064 @default.
• W2003183855 hasConcept C178790620 @default.
• W2003183855 hasConcept C178907741 @default.
• W2003183855 hasConcept C179104552 @default.
• W2003183855 hasConcept C185592680 @default.
• W2003183855 hasConcept C191897082 @default.
• W2003183855 hasConcept C192562407 @default.
• W2003183855 hasConcept C207001950 @default.
• W2003183855 hasConcept C2776568683 @default.
• W2003183855 hasConcept C2776970183 @default.
• W2003183855 hasConcept C2779400197 @default.
• W2003183855 hasConcept C2780105360 @default.
• W2003183855 hasConcept C2780828025 @default.
• W2003183855 hasConcept C2781324293 @default.
• W2003183855 hasConcept C40875361 @default.
• W2003183855 hasConcept C86803240 @default.
• W2003183855 hasConceptScore W2003183855C134121241 @default.
• W2003183855 hasConceptScore W2003183855C135731615 @default.
• W2003183855 hasConceptScore W2003183855C150903083 @default.
• W2003183855 hasConceptScore W2003183855C155647269 @default.
• W2003183855 hasConceptScore W2003183855C161790260 @default.
• W2003183855 hasConceptScore W2003183855C177322064 @default.
• W2003183855 hasConceptScore W2003183855C178790620 @default.
• W2003183855 hasConceptScore W2003183855C178907741 @default.
• W2003183855 hasConceptScore W2003183855C179104552 @default.
• W2003183855 hasConceptScore W2003183855C185592680 @default.
• W2003183855 hasConceptScore W2003183855C191897082 @default.
• W2003183855 hasConceptScore W2003183855C192562407 @default.
• W2003183855 hasConceptScore W2003183855C207001950 @default.
• W2003183855 hasConceptScore W2003183855C2776568683 @default.

• next